The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118988314 11898831 4 F 20130403 20160805 20160108 20160813 EXP JP-AMGEN-JPNCT2015141264 AMGEN 77.00 YR E M Y 66.00000 KG 20160812 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118988314 11898831 1 PS romiplostim ROMIPLOSTIM 1 Subcutaneous 1 MUG/KG, QD 125268 1 UG/KG INVESTIGATIONAL DOSAGE FORM QD
118988314 11898831 2 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 2 MUG/KG, QD 125268 2 UG/KG INVESTIGATIONAL DOSAGE FORM QD
118988314 11898831 3 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 3 MUG/KG, QD 125268 3 UG/KG INVESTIGATIONAL DOSAGE FORM QD
118988314 11898831 4 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 4 MUG/KG, QD 125268 4 UG/KG INVESTIGATIONAL DOSAGE FORM QD
118988314 11898831 5 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 3 MUG/KG, QD 125268 3 UG/KG INVESTIGATIONAL DOSAGE FORM QD
118988314 11898831 6 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 2 MUG/KG, QWK 125268 2 UG/KG INVESTIGATIONAL DOSAGE FORM /wk
118988314 11898831 7 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 3 MUG/KG, QWK 125268 3 UG/KG INVESTIGATIONAL DOSAGE FORM /wk
118988314 11898831 8 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 3 MUG/KG, QWK 125268 3 UG/KG INVESTIGATIONAL DOSAGE FORM /wk
118988314 11898831 9 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 3 MUG/KG, QWK 125268 3 UG/KG INVESTIGATIONAL DOSAGE FORM /wk
118988314 11898831 10 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 3 MUG/KG, QWK 125268 3 UG/KG INVESTIGATIONAL DOSAGE FORM /wk
118988314 11898831 11 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 3 MUG/KG, QWK 125268 3 UG/KG INVESTIGATIONAL DOSAGE FORM /wk
118988314 11898831 12 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 3 MUG/KG, QWK 125268 3 UG/KG INVESTIGATIONAL DOSAGE FORM /wk
118988314 11898831 13 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 4 MUG/KG, QD 125268 4 UG/KG INVESTIGATIONAL DOSAGE FORM QD
118988314 11898831 14 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 5 MUG/KG, QWK 125268 5 UG/KG INVESTIGATIONAL DOSAGE FORM /wk
118988314 11898831 15 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 5 MUG/KG, QWK 125268 5 UG/KG INVESTIGATIONAL DOSAGE FORM /wk
118988314 11898831 16 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 4 MUG/KG, QWK 125268 4 UG/KG INVESTIGATIONAL DOSAGE FORM /wk
118988314 11898831 17 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 2 MUG/KG, QWK 125268 2 UG/KG INVESTIGATIONAL DOSAGE FORM /wk
118988314 11898831 18 SS romiplostim ROMIPLOSTIM 1 Subcutaneous 1 MUG/KG, QWK 125268 1 UG/KG INVESTIGATIONAL DOSAGE FORM /wk
118988314 11898831 19 SS PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral UNK 0 TABLET
118988314 11898831 20 C MUCOSOLVAN AMBROXOL HYDROCHLORIDE 1 Oral 45 MG, UNK 0 45 MG TABLET
118988314 11898831 21 C DAIKENCHUTO HERBALS 1 Oral 3 G, UNK 0 3 G
118988314 11898831 22 C FERROUS SULFATE. FERROUS SULFATE 1 Oral 105 MG, UNK 0 105 MG TABLET
118988314 11898831 23 C ALLEGRA FEXOFENADINE HYDROCHLORIDE 1 Oral 120 MG, UNK 0 120 MG TABLET
118988314 11898831 24 C GASTROM ECABET 1 Oral 2 G, UNK 0 2 G
118988314 11898831 25 C DEPAS ETIZOLAM 1 Oral 1 MG, UNK 0 1 MG TABLET
118988314 11898831 26 C PARIET RABEPRAZOLE SODIUM 1 Oral 10 MG, UNK 0 10 MG TABLET
118988314 11898831 27 C GASMOTIN MOSAPRIDE CITRATE 1 Oral 15 MG, UNK 0 15 MG TABLET
118988314 11898831 28 C GASMOTIN MOSAPRIDE CITRATE 1 Oral 15 MG, UNK 0 15 MG TABLET
118988314 11898831 29 C GASMOTIN MOSAPRIDE CITRATE 1 Oral 15 MG, UNK 0 15 MG TABLET
118988314 11898831 30 C BERIZYM CELLULASEDIASTASELIPASE 1 Oral 3 G, UNK 0 3 G
118988314 11898831 31 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral UNK 0 CAPSULE
118988314 11898831 32 C TEPRENONE TEPRENONE 1 Oral UNK 0 CAPSULE
118988314 11898831 33 C CEFAZOLIN NA 2 Unknown UNK 0 INJECTION
118988314 11898831 34 C FAMOTIDINE. FAMOTIDINE 1 Unknown UNK 0 INJECTION
118988314 11898831 35 C TRANEXAMIC ACID C TRANEXAMIC ACID 1 Oral UNK 0 CAPSULE
118988314 11898831 36 C MUCODYNE CARBOCYSTEINE 1 Oral UNK 0 TABLET
118988314 11898831 37 C ETIZOLAM ETIZOLAM 1 Oral UNK 0 TABLET
118988314 11898831 38 C ALENDRONATE ALENDRONATE SODIUM 1 Oral UNK 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118988314 11898831 1 Product used for unknown indication
118988314 11898831 19 Haemolytic anaemia
118988314 11898831 20 Abdominal symptom
118988314 11898831 21 Abdominal symptom
118988314 11898831 22 Abdominal symptom
118988314 11898831 23 Rhinitis allergic
118988314 11898831 24 Abdominal symptom
118988314 11898831 25 Abdominal symptom
118988314 11898831 26 Abdominal symptom
118988314 11898831 27 Abdominal symptom
118988314 11898831 30 Abdominal symptom
118988314 11898831 31 Prophylaxis
118988314 11898831 32 Abdominal symptom
118988314 11898831 33 Prophylaxis
118988314 11898831 34 Prophylaxis
118988314 11898831 36 Abdominal symptom
118988314 11898831 37 Abdominal symptom
118988314 11898831 38 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
118988314 11898831 HO
118988314 11898831 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118988314 11898831 Muscle abscess
118988314 11898831 Nasopharyngitis
118988314 11898831 Nausea
118988314 11898831 Post procedural infection
118988314 11898831 Procedural pain
118988314 11898831 Pyrexia
118988314 11898831 Upper respiratory tract infection
118988314 11898831 Upper respiratory tract inflammation
118988314 11898831 Vomiting
118988314 11898831 White blood cell count increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118988314 11898831 1 20120601 0
118988314 11898831 2 20120608 0
118988314 11898831 3 20120615 0
118988314 11898831 4 20120620 0
118988314 11898831 5 20120627 0
118988314 11898831 6 20120704 0
118988314 11898831 7 20120725 0
118988314 11898831 8 20121116 0
118988314 11898831 9 20121126 0
118988314 11898831 10 20130105 0
118988314 11898831 11 20130116 0
118988314 11898831 12 20130116 0
118988314 11898831 13 20130130 0
118988314 11898831 14 20130206 0
118988314 11898831 15 20130206 0
118988314 11898831 16 20130327 0
118988314 11898831 17 20130508 0
118988314 11898831 18 20130605 0
118988314 11898831 20 20120521 20120618 0
118988314 11898831 21 20120521 20121112 0
118988314 11898831 22 20120521 20121101 0
118988314 11898831 23 20120525 20120607 0
118988314 11898831 24 20120525 20120607 0
118988314 11898831 25 20120525 20120607 0
118988314 11898831 26 20120525 20120607 0
118988314 11898831 27 20120601 20121112 0
118988314 11898831 28 20120601 20120607 0
118988314 11898831 29 20121030 20121112 0
118988314 11898831 30 20120615 20121112 0

Execution Time: 0.0073299407958984 seconds (ucode:5066224). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.